ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 268

Knee Osteoarthritis and Serum Uric Acid Concentration: The Third National Health and Examination Survey

Tony Ning1, Carl Pieper2, Virginia B. Kraus3, William E. Kraus4 and Kim M. Huffman4, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, 3Medicine/Rheumatology, Duke University Medical Center, Durham, NC, 4Medicine, Duke University Medical Center, Durham, NC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, osteoarthritis and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

 Osteoarthritis (OA) is a disease that is thought to be the result of many factors, which includes inflammatory causes.  A recent study examined the relation of knee OA, synovial uric acid levels, and how it relates to NLRP3 inflammasome activity.  It was demonstrated that synovial uric acid concentration is strongly correlated with markers of inflammasome activity and knee osteoarthritis.  In addition, baseline synovial TNF alpha and synovial IL-18 was associated with changes in the osteophyte scores in 3 year longitudinal models of knee.  This main focus of our research project is to examine the relation of serum uric acid concentration (SUA) and the severity of radiographic knee osteoarthritis.  We hypothesized that higher concentrations of SUA is positively associated with the severity of radiographic knee OA as measured by Kellgren/Lawrence grades.

Methods:

We used the National Health and Nutrition Examination Survey  (NHANES III) database to carry out our research.  Patients over the age of 60 had bilateral, non weight bearing knee films done.  Our database was created by merging variable datasets provided by the NHANES III, which included lab values, knee imaging, demographics, as well as physical exam findings.  A total of 2188 survey participants were in our database after excluding patients who either had gout or were on allopurinol. We performed correlative analyses between serum uric acid concentrations and different measurements of knee osteoarthritis using SAS Enterprise Guide version 2.3.  The correlation between serum uric acid concentration and knee osteoarthritis was examined with Pearson’s score of correlation.  Co-variates were taken into account using generalized linear modeling.  The NHANEs survey design was taken into account by applying sampling weights to our variables.

Results:

A statistically significant correlation was seen in univariate analyses between serum uric acid concentration and measurements of radiographic knee OA, which included the  combined total KL score (R=0.086, p<0.001), the combined total medial tibial sclerosis score (R=0.053, p=.01), and the combined total osteophyte score (R=0.069, p=0.001).  Linear regression modeling was then preformed between the measurements of knee osteoarthritis and serum uric acid concentration to account for age, gender, body mass index (BMI), serum creatinine (Cr).  Statistical significance was lost when accounting for these covariates.

Conclusion:  

In conclusion, our study showed a statistically significant correlation between serum uric acid concentration and radiographic measurements of knee osteoarthritis.  This relationship was lost while accounting for age, gender, BMI, and serum creatinine.  It is likely that soluble uric acid acts locally in increasing risk for OA.


Disclosure:

T. Ning,
None;

C. Pieper,
None;

V. B. Kraus,
None;

W. E. Kraus,
None;

K. M. Huffman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-osteoarthritis-and-serum-uric-acid-concentration-the-third-national-health-and-examination-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology